Skip to main content

Peer Review reports

From: Potential clinical application of anti-Müllerian hormone testing in radioiodine treatment of thyroid carcinoma

Original Submission
12 Dec 2023 Submitted Original manuscript
13 Mar 2024 Reviewed Reviewer Report
20 Mar 2024 Reviewed Reviewer Report - Patroklos Katafygiotis
9 Apr 2024 Author responded Author comments - Barbora Havlínová
Resubmission - Version 2
9 Apr 2024 Submitted Manuscript version 2
12 Apr 2024 Author responded Author comments - Barbora Havlínová
Resubmission - Version 3
12 Apr 2024 Submitted Manuscript version 3
18 Apr 2024 Reviewed Reviewer Report - Patroklos Katafygiotis
20 Apr 2024 Reviewed Reviewer Report
25 Apr 2024 Author responded Author comments - Barbora Havlínová
Resubmission - Version 4
25 Apr 2024 Submitted Manuscript version 4
6 May 2024 Author responded Author comments - Barbora Havlínová
Resubmission - Version 5
6 May 2024 Submitted Manuscript version 5
8 May 2024 Author responded Author comments - Barbora Havlínová
Resubmission - Version 6
8 May 2024 Submitted Manuscript version 6
9 May 2024 Author responded Author comments - Barbora Havlínová
Resubmission - Version 7
9 May 2024 Submitted Manuscript version 7
Publishing
13 May 2024 Editorially accepted
23 May 2024 Article published 10.1186/s13104-024-06802-y

You can find further information about peer review here.

Back to article page